Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2026 Filed Feb 21, 2026 01:36 UTC |
WYSZOMIERSKI JACK LDirector
|
SaleCommon Stock | 99,574 | $44.01 | $4,382,251.74 |
DisclosureSEC source: 0000939767-26-000030 · wk-form4_1771637788.xml · nonDerivative · entry 2 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 279,942 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 18, 2026 Filed Feb 21, 2026 01:36 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionCommon Stock | 20,634 | $19.77 | $407,934.18 |
DisclosureSEC source: 0000939767-26-000030 · wk-form4_1771637788.xml · nonDerivative · entry 1 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 379,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:49 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 30,617 | $43.67 | $1,337,044.39 |
DisclosureSEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 3 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 976,092 F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:49 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 64,778 | $43.50 | $2,817,843.00 |
DisclosureSEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,908 F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:49 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 3,036 | $43.84 | $133,098.24 |
DisclosureSEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,686 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 250,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,965,140 F4 · kind: On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F5 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 250,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579,209 F4 · kind: On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionOption (right to buy) · Derivative | 42,422 | $0.00 Strike: $18.19 | $0.00 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · derivative · entry 7 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,422 shares Expires 2029-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
SaleCommon Stock | 42,422 | $43.33 | $1,838,145.26 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 2 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,590 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:18 UTC |
Smith JulieDirector
|
Exercise / conversionCommon Stock | 42,422 | $18.19 | $771,656.18 |
DisclosureSEC source: 0000939767-26-000029 · wk-form4_1771546714.xml · nonDerivative · entry 1 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:49 UTC |
Senner Christopher J.EVP and CFO
|
Tax withholdingCommon Stock | 35,870 | $43.92 | $1,575,410.40 |
DisclosureSEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 2 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006,709 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:49 UTC |
Haley Patrick J.EVP, Commercial
|
Tax withholdingCommon Stock | 31,483 | $43.92 | $1,382,733.36 |
DisclosureSEC source: 0000939767-26-000027 · wk-form4_1771465761.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,722 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. F2 · balance_after: Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 120,390 | $43.92 | $5,287,528.80 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,829,945 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:49 UTC |
Aftab DanaEVP, Research and Development
|
Tax withholdingCommon Stock | 12,720 | $43.92 | $558,662.40 |
DisclosureSEC source: 0000939767-26-000024 · wk-form4_1771465741.xml · nonDerivative · entry 2 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,897 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on January 5, 2023. F2 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:49 UTC |
Aftab DanaEVP, Research and Development
|
Tax withholdingCommon Stock | 26,485 | $43.92 | $1,163,221.20 |
DisclosureSEC source: 0000939767-26-000024 · wk-form4_1771465741.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,617 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. F2 · balance_after: Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 01:48 UTC |
Hefti BrendaSVP and General Counsel
|
Tax withholdingCommon Stock | 5,430 | $43.92 | $238,485.60 |
DisclosureSEC source: 0000939767-26-000022 · wk-form4_1771465726.xml · nonDerivative · entry 1 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,181 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. F2 · balance_after: Includes 95,956 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:49 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 34,278 | $43.00 | $1,473,954.00 |
DisclosureSEC source: 0000939767-26-000028 · wk-form4_1771465767.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,042,579 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 494,700 | $0.00 Strike: $21.31 | $0.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · derivative · entry 9 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 494,700 shares Expires 2028-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option, representing the right to purchase a total of 494,700 shares of Common Stock, became fully exercisable on March 4, 2025. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 369,606 | $43.92 | $16,233,095.52 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,950,335 F2 · shares: Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on January 13, 2026 of $43.92. F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:49 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 494,700 | $21.31 | $10,542,057.00 |
DisclosureSEC source: 0000939767-26-000026 · wk-form4_1771465753.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,319,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:49 UTC |
Eckhardt Sue GailDirector
|
SaleCommon Stock | 3,856 | $43.79 | $168,854.24 |
DisclosureSEC source: 0000939767-26-000025 · wk-form4_1771465747.xml · nonDerivative · entry 1 Eckhardt Sue Gail · CIK 0001823769 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,524 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:48 UTC |
Oliver BobDirector
|
Exercise / conversionOption (right to buy) · Derivative | 9,088 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · derivative · entry 4 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,118 Underlying: Common Stock · 9,088 shares Expires 2030-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:48 UTC |
Oliver BobDirector
|
SaleCommon Stock | 21,162 | $43.90 | $929,011.80 |
DisclosureSEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 3 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,120 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:48 UTC |
Oliver BobDirector
|
SaleCommon Stock | 9,088 | $43.61 | $396,327.68 |
DisclosureSEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 2 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,282 F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 01:48 UTC |
Oliver BobDirector
|
Exercise / conversionCommon Stock | 9,088 | $19.28 | $175,216.64 |
DisclosureSEC source: 0000939767-26-000023 · wk-form4_1771465734.xml · nonDerivative · entry 1 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Aftab DanaEVP, Research and Development
|
Tax withholdingCommon Stock | 27,254 | $45.23 | $1,232,698.42 |
DisclosureSEC source: 0000939767-26-000006 · wk-form4_1768608171.xml · nonDerivative · entry 2 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 733,102 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026. F3 · balance_after: Includes 491,096 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Aftab DanaEVP, Research and Development
|
GrantCommon Stock | 119,578 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000006 · wk-form4_1768608171.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,356 F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 68,331 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 491,096 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:03 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 139,524 | $45.23 | $6,310,670.52 |
DisclosureSEC source: 0000939767-26-000007 · wk-form4_1768608177.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,825,241 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026. F3 · balance_after: Includes 1,690,729 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:03 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GrantCommon Stock | 548,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000007 · wk-form4_1768608177.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,964,765 F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 313,185 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 1,690,729 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Haley Patrick J.EVP, Commercial
|
Tax withholdingCommon Stock | 32,332 | $45.23 | $1,462,376.36 |
DisclosureSEC source: 0000939767-26-000005 · wk-form4_1768608166.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,205 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026. F3 · balance_after: Includes 443,784 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Haley Patrick J.EVP, Commercial
|
GrantCommon Stock | 139,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000005 · wk-form4_1768608166.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,537 F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 79,719 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 443,784 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Senner Christopher J.EVP and CFO
|
Tax withholdingCommon Stock | 40,459 | $45.23 | $1,829,960.57 |
DisclosureSEC source: 0000939767-26-000004 · wk-form4_1768608160.xml · nonDerivative · entry 2 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,857 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026. F3 · balance_after: Includes 494,177 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 00:02 UTC |
Senner Christopher J.EVP and CFO
|
GrantCommon Stock | 149,474 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000004 · wk-form4_1768608160.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,117,316 F1 · date: On April 3, 2023, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 85,414 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the eligible Target Shares vest upon the Compensation Committee's (the "Committee") certification of achievement of certain performance criteria; and (ii) 50% of the eligible Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 175% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F2 · shares: On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's certification on January 15, 2026 resulted in the immediate vesting of 50% of the Achieved Shares, and the remaining 50% of the Achieved Shares will vest on February 15, 2027, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 494,177 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 23:51 UTC |
Hefti BrendaSVP and General Counsel
|
GrantCommon Stock | 30,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000141 · wk-form4_1764978676.xml · nonDerivative · entry 1 Hefti Brenda · CIK 0002097579 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,611 F1 · date: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on February 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each February 15th until fully vested. F1 · shares: Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on February 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each February 15th until fully vested. F2 · balance_after: Includes 110,745 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:05 UTC |
JOHNSON DAVID EDWARDDirector
Caligan Partners LPDirector · See Remarks
|
PurchaseCommon Stock | 27,532 | $43.12 | $1,187,234.90 |
DisclosureSEC source: 0000902664-25-005164 · ownership.xml · nonDerivative · entry 1 JOHNSON DAVID EDWARD · CIK 0001785557 · Director Caligan Partners LP · CIK 0001727492 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,553,262 F1 · ownership.nature: This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 00:47 UTC |
Aftab DanaEVP, Research and Development
|
GiftCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000139 · wk-form4_1764031668.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,778 F1 · kind: On November 21, 2025, the Reporting Person gifted 24,000 shares of Exelixis Inc. common stock ("Common Stock") to a donor-advised fund. F2 · balance_after: Includes 431,306 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 00:47 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 28,043 | $42.58 | $1,194,070.94 |
DisclosureSEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 4 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,029 F5 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4. F2 · balance_after: Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| November 20, 2025 Filed Nov 25, 2025 00:47 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 10,648 | $41.77 | $444,766.96 |
DisclosureSEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Indirect · By 401(k) Disclosed balance after: 0 F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| November 20, 2025 Filed Nov 25, 2025 00:47 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 23,539 | $41.93 | $986,990.27 |
DisclosureSEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 0 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| November 20, 2025 Filed Nov 25, 2025 00:47 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 10,000 | $42.11 | $421,100.00 |
DisclosureSEC source: 0000939767-25-000140 · wk-form4_1764031675.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,072 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 01:11 UTC |
Oliver BobDirector
|
GiftCommon Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000138 · wk-form4_1763601062.xml · nonDerivative · entry 1 Oliver Bob · CIK 0001694534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,282 F1 · kind: On November 17, 2025, the Reporting Person gifted 1,044 shares of Exelixis, Inc. common stock ("Common Stock") to a not-for-profit organization. F2 · balance_after: Includes 18,900 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 00:12 UTC |
PAPADOPOULOS STELIOSDirector
|
SaleCommon Stock | 100,000 | $43.55 | $4,355,000.00 |
DisclosureSEC source: 0000939767-25-000137 · wk-form4_1763079170.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,189,228 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.55 to $43.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 00:12 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,714,404 F4 · kind: On November 12, 2025, the Reporting Person gifted 80,000 shares of Common Stock to a donor advised fund. F5 · balance_after: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 00:12 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 101,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,794,404 F2 · kind: On November 12, 2025, the Reporting Person gifted 101,548 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 00:12 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 101,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,416,692 F2 · kind: On November 12, 2025, the Reporting Person gifted 101,548 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F3 · balance_after: Includes 1,416,692 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:12 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000136 · wk-form4_1763079162.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,692,856 F1 · kind: On November 11, 2025, the Reporting Person gifted 160,000 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:12 UTC |
Aftab DanaEVP, Research and Development
|
SaleCommon Stock | 48,383 | $42.50 | $2,056,277.50 |
DisclosureSEC source: 0000939767-25-000135 · wk-form4_1763079156.xml · nonDerivative · entry 1 Aftab Dana · CIK 0001959132 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664,778 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 431,306 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:12 UTC |
Beckerle Mary CDirector
|
Exercise / conversionOption (right to buy) · Derivative | 5,784 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · derivative · entry 4 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,710 Underlying: Common Stock · 5,784 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:12 UTC |
Beckerle Mary CDirector
|
SaleCommon Stock | 18,838 | $41.90 | $789,312.20 |
DisclosureSEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · nonDerivative · entry 3 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,380 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · balance_after: Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:12 UTC |
Beckerle Mary CDirector
|
SaleCommon Stock | 5,784 | $42.03 | $243,101.52 |
DisclosureSEC source: 0000939767-25-000134 · wk-form4_1763079150.xml · nonDerivative · entry 2 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,218 F1 · balance_after: Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.